• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. No Sign of Slowdown in Biotech M&A

    High levels of merger and acquisition activity will be the big theme of year for biotech, says Morningstar's Lauren Migliore.

  2. Top Biotech Acquisition Candidates

    2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.

  3. Our Top Five Biotech Takeout Picks

    Health-care analyst Lauren Migliore looks at what makes a biotech firm a likely takeout candidate and reveals our top five biotech M&A picks for 2010.

  4. Our Top Five Biotech Acquisition Candidates

    M&A activity grew in 2010, and we expect deal volume to remain strong in 2011.

  1. Financial Planning for Athletes: 6 Rules for Success

    Working with sports stars can be prestigious, even glamorous -- and is often a highly sought after market niche for financial advisors and wealth managers, but professional athletes can also present advisors with a minefield of challenges

  2. Next Up for SEC's Champ? Money Fund Reforms, Valuation Guidance

    Norm Champ has been on the job as Director of the Division of Investment Management at the Securities and Exchange Commission for eight months and a lot of mutual fund executives are nervously waiting for the SEC has in store for the industry in 2013 and beyond.

  3. State of the Sector: Health Care

     

  4. Check In to Lodging Operators That Manage as Well as Franchise

    Economic moats, stronger growth prospects, and other advantages cause us to favor operators that both manage and franchise hotels.

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.